Latest news

October 25, 2023

Debiopharm invests over 30 million on innovation when its workforce jumped 33% in Valais in one year

Read more
March 29, 2023

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Read more
February 25, 2021

Debiopharm and Genome & Company Join Forces to Create New Highly Specific Therapies For Cancer Patients

Read more
January 7, 2019

Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America

Read more
December 13, 2017

Debiopharm et la HES-SO Valais-Wallis célèbrent 20 ans de partenariat public-privé en collaborant au développement d’une nouvelle technologie de marquage…

Read more
September 17, 2015

Debiopharm Group™ inaugure son site de production et son laboratoire de recherche après 18 mois de travaux, à Martigny.

Read more
March 6, 2014

Debiopharm Group™ to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)

Read more
July 14, 2011

Continuity as Debiopharm Group™ management moves forward

Read more
November 23, 2010

Abionic wins the ‘Prix Debiopharm Valais pour les Sciences de la Vie’ for its innovative biomedical device for diagnostic testing

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Research & Manufacturing, subscribe to our newsletter.